Recombinant or peptide antigens in the serology of lyme arthritis in children

Journal of Infectious Diseases

Volumn 187, Issue 12, 2003, Pages 1888-1894

  Heikkilä, Tero ^a,b   Huppertz, Hans Iko ^d,e   Seppälä, Ilkka ^b,c   Sillanpää, Heidi ^b   Saxen, Harri ^a   Lahdenne, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Prof Hess Children's Hospital   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; BINDING PROTEIN; DECORIN; DECORIN BINDING PROTEIN A ANTIGEN; DECORIN BINDING PROTEIN B ANTIGEN; IMMUNOGLOBULIN G; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CHILD; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; TREATMENT OUTCOME;

EID: 0038239183     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375371     Document Type: Article

References (29)

1. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20:7-17.
2. Huppertz HI, Karch H, Suschke HJ, et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 1995; 38:361-8.
3. Wormser GP, Nowakowski J, Nadelman RB, Bittker S, Cooper D, Pavia C. Improving the yield of blood cultures for patients with early Lyme disease. J Clin Microbiol 1998; 36:296-8.
4. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352:557-65.
5. Sigal LH. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum 1998; 41:195-204.
6. Brown SL, Hansen SL, Langone JJ. Role of serology, in the diagnosis of Lyme disease. JAMA 1999; 282:62-6.
7. Goossens HAT, van den Bogaard AE, Nohlmans MKE. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1999; 18:551-60.
8. Hauser U, Krahl H, Peters H, Fingerle V, Wilske B. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assay using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1998; 36:427-36.
9. Robertson J, Guy E, Andrews N, et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38:2097-102.
10. Magnarelli LA, Fikrig E, Padula SJ, Aderson JF, Flavell RA. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol 1996; 34:237-40.
11. Magnarelli LA, Ijdo JW, Padula SJ, Anderson JF, Flavell RA, Fikrig E. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J Clin Microbiol 2000; 38: 1735-9.
12. Heikkilä T, Seppälä I, Saxen H, Panelius J, Yrjänäinen H, Lahdenne P. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J Clin Microbiol 2002; 40:453-60.
13. Heikkilä T, Seppälä I, Saxen H, et al. Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis. J Clin Microbiol 2002; 40:1174-80.
14. Heikkilä T, Seppälä I, Saxen H, et al. Cloning of the gene encoding the decorin-binding protein B (DbpB) in Borrelia burgdorferi sensu lato and characterization of the antibody response to DbpB in Lyme borreliosis. J Med Microbiol 2002; 51:641-8.
15. Wilske B, Habermann C, Fingerle V, et al. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol 1999; 188:139-44.
16. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 1999; 37:3990-6.
17. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74:829-36.
18. 6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and humans. J Infect Dis 2001; 184:870-8.
19. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999; 12:633-53.
20. Hubalek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidemiol 1997; 13:951-7.
21. Jaulhac B, Chary-Valckenaere I, Sibilia J, et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 1996; 39:736-45.
22. Lunemann JD, Zarmas S, Priem S, et al. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol 2001; 39:1130-3.
23. Vasiliu V, Herzer P, Rössler D, Lehnert G, Wilske B. Heterogeneity, of Borrelia burgdorferi sensu lato demonstrated by an ospA- type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol 1998; 187:97-102.
24. Eiffert H, Karsten A, Thomssen R, Christen HJ. Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis 1998; 30: 265-8.
25. Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun 1999; 67:173-81.
26. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis 2001; 33:780-5.
27. Bentas W, Karch H, Huppertz HI. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol 2000; 27:2025-30.
28. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998; 281:703-6.
29. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.